CDK-TCIP2
DK-TCIP2 is a bifunctional small molecule research compound combining a CDK9 inhibitor with a BCL6 inhibitor. It demonstrates potent anticancer activity in both in vitro and in vivo models, making it a valuable tool for investigating therapeutic strategies in lymphoma research.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog